Discover and read the best of Twitter Threads about #divislaboratories
Most recents (2)
#DivisLaboratories Q3 FY22 concall highlights 💊💊
Like & retweet for better reach !
1. Revenues for the quarter stood at ₹2510 Cr (46% growth YoY).
2. PBT for the quarter stood at ₹1034 Cr (61% growth YoY).
Like & retweet for better reach !
1. Revenues for the quarter stood at ₹2510 Cr (46% growth YoY).
2. PBT for the quarter stood at ₹1034 Cr (61% growth YoY).
3. Exports contributed to 92% of revenues for the quarter. Europe and the US contributed to 79% of revenues .
4. Generics contributed to 40% and Custom Synthesis contributed to 60% of revenues for the quarter. Nutraceutical business contributed ₹166 Cr for the quarter.
4. Generics contributed to 40% and Custom Synthesis contributed to 60% of revenues for the quarter. Nutraceutical business contributed ₹166 Cr for the quarter.
5. They have capitalized ₹196 Cr of capex during the quarter and ₹762 Cr for 9 months. They expect another ₹100 Cr to be capitalized by the end of the financial year. Capex in the new SEZ accounted for ₹368 Cr.
#MCProOpinion | Divi’s is well placed to benefit from increased sourcing by global innovators seeking to lower dependence on China. But risks exist, writes R Sree Ram
#DivisLaboratories #Markets
moneycontrol.com/news/opinion/h…
#DivisLaboratories #Markets
moneycontrol.com/news/opinion/h…
#MCProOpinion | There has been much talk about mitigating the impact of climate change at the macro level. The concerns are now percolating down to its impact on companies: Sundeep Khanna (@companyoutsider)
#ClimateChange #ClimateAction
moneycontrol.com/news/opinion/c…
#ClimateChange #ClimateAction
moneycontrol.com/news/opinion/c…
What could spoil the party in the markets? The return of inflation is one risk that many are flagging, Manas Chakravarty writes for #MCProOpinion
#Inflation #Markets #Economy
moneycontrol.com/news/opinion/c…
#Inflation #Markets #Economy
moneycontrol.com/news/opinion/c…
